| 摘要 |
<p>The invention relates to new crystalline forms I, II and III (±)-1-[2-dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol-hydrochloride of the Formula (I) and hydrates thereof. The new polymorphs are of uniform morphology and can be used in therapy as antidepressant.</p> |
